Nerve Repair through Muscle Progenitor Cell Transplantation
Nerve Repair through Muscle Progenitor Cell Transplantation
批准号:
8426241
负责人:
Johnny Huard
金额:
$18.94万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2014-08-31
关键词:
AdultApplications GrantsAreaAtrophicAxonBiological AssayBlood VesselsBone Marrow TransplantationBrain-Derived Neurotrophic FactorCardiacCell Differentiation processCell TherapyCellsCuesDataDefectEndothelial CellsFluorescence-Activated Cell SortingGoalsGrowthHealedHeartHumanImmobilized CellsImplantIn VitroInflammatoryInjection of therapeutic agentInjuryLightMediatingMusMuscleMusculoskeletalMusculoskeletal SystemMyoblastsMyocardiumNatural regenerationNerveNerve FibersNerve RegenerationNeurogliaNeuronsOutcomePericytesPeripheral NervesPlayPopulationProcessProliferatingQualifyingReportingResearchSiteSkeletal MuscleStem cell transplantStem cellsSuspension substanceSuspensionsTechniquesTherapeuticTimeTissuesTransplantationVascular Endothelial Growth Factorsangiogenesisarticular cartilagebasebonefunctional restorationhealingimplantationimprovedin vivoindexinginjuredloss of functionmuscle transplantationnerve injuryregenerativerepairedresearch studyscaffoldsciatic nervestressortissue repair
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Muscle Progenitor Cells (MPCs) isolated from skeletal muscle have been shown to be both multipotent and of significant therapeutic value for the repair of various tissues of the musculoskeletal system, including skeletal and cardiac muscles, bone and articular cartilage, yet their ability to undergo neurogenic differentiation has not been fully investigated. We have recently observed that mice and human MPCs are capable of undergoing in vitro and in vivo neurogenic and glial cell differentiation, and inducing functionl healing of sciatic nerve defects in mice. The repair process, determined by histological and immunohistochemical analyses, were also validated by a functional assay (sciatic functional index). Although we have reported that both murine MPCs (mMPCs) and human MPCs (hMPCs) promoted axonal in-growth through their differentiation into glial cells, it is likely that
the use of a scaffold to immobilize the injected cells at the injury site could further promote nerve repair. Since we have recently shown that the use of cell sheets as a stem cell delivery vehicle, which immobilizes the cells at the site of injury, further improved the beneficial effect imparted by the stem cells on the injured cardiac and ligamentous tissues, we are proposing to characterize whether the nerve repair process could be enhanced, through the use of a cell sheet comprised of MPCs (Aim #1). Since we have observed that the regenerative potential of MPCs in various tissues correlates with the ability of the cells to induce angiogenesis, we posit that a similar mechanism may explain the beneficial effect imparted by the MPCs in nerve repair. Indeed, it has been observed that VEGF administration can support the growth of regenerating nerve fibers through the process of angiogenesis; moreover, the beneficial effect imparted by bone marrow transplantation on nerve repair appears to occur through the secretion of various trophic factors that promote axon angiogenesis. We are proposing to determine the influence that angiogenesis plays in the nerve healing process (Aim #2) through gain and loss of function experiments using VEGF and sFlt-1 expressing MPCs. Successful completion of these aims will not only provide exciting results for quantitative evidence of the efficacy of MPC transplantation to improve nerve healing, but could also shed light on the mechanism(s) of action by which progenitor cells interact with the microenvironment (especially via angiogenesis) at the site of nerve injury.
PUBLIC HEALTH RELEVANCE: This grant application focuses on the use of muscle-derived progenitor cells to improve peripheral nerve repair through the use of cell sheets as a new delivery vehicle to immobilize progenitor cells at the site of injury to further promote nerve repar (Aim 1) and to determine the influence that angiogenesis (Aim 2) has on the repair process mediated by muscle progenitor cells during nerve regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
-
批准号:10468269
-
项目类别:
-
资助金额:$62.11万
-
财政年份:2020
-
负责人:Johnny Huard
-
依托单位:
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
-
批准号:10044832
-
项目类别:
-
资助金额:$52.23万
-
财政年份:2020
-
负责人:Johnny Huard
-
依托单位:
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
-
批准号:10416892
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2020
-
负责人:Johnny Huard
-
依托单位:
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
-
批准号:10688127
-
项目类别:
-
资助金额:$60.01万
-
财政年份:2020
-
负责人:Johnny Huard
-
依托单位:
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
-
批准号:10401197
-
项目类别:
-
资助金额:$63.38万
-
财政年份:2020
-
负责人:Johnny Huard
-
依托单位:
Effects of Circulating Factors and Progenitors on Wound Healing during Pregnancy
-
批准号:9917947
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2019
-
负责人:Johnny Huard
-
依托单位:
Ablation of Non-Myogenic Progenitor Cells as a New Therapeutic Approach to Duchenne Muscular Dystrophy
-
批准号:10013124
-
项目类别:
-
资助金额:$14.92万
-
财政年份:2019
-
负责人:Johnny Huard
-
依托单位:
Development of biological approaches to enhance skeletal muscle rehabilitation after anterior cruciate ligament injury
-
批准号:9809778
-
项目类别:
-
资助金额:$18.85万
-
财政年份:2019
-
负责人:Johnny Huard
-
依托单位:
Bone Abnormalities & Healing Defect in Muscular Dystrophy
-
批准号:9263882
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2014
-
负责人:Johnny Huard
-
依托单位:
The Use of Coacervate Technology as a New Drug Delivery System for Musculoskeleta
-
批准号:8681855
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2014
-
负责人:Johnny Huard
-
依托单位:
The Use of Coacervate Technology as a New Drug Delivery System for Musculoskeleta
-
批准号:9130004
-
项目类别:
-
资助金额:$17.85万
-
财政年份:2014
-
负责人:Johnny Huard
-
依托单位:
Biomimetic Coacervate Delivery of Muscle Stem Cell to Improve Cardiac Repair
-
批准号:8636750
-
项目类别:
-
资助金额:$19.43万
-
财政年份:2014
-
负责人:Johnny Huard
-
依托单位:
Nerve Repair through Muscle Progenitor Cell Transplantation
-
批准号:8539112
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2012
-
负责人:Johnny Huard
-
依托单位:
Muscle stem cell therapy in a mouse model of premature aging
-
批准号:7916407
-
项目类别:
-
资助金额:$18.36万
-
财政年份:2009
-
负责人:Johnny Huard
-
依托单位:
Muscle Stem Cell-based therapies for Cardiomyopathy
-
批准号:7663826
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2008
-
负责人:Johnny Huard
-
依托单位:
Muscle-based Tissue Engineering to Improve Bone Healing
-
批准号:7433815
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2006
-
负责人:Johnny Huard
-
依托单位:
Muscle-based tissue engineering to improve bone healing
-
批准号:7924863
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2001
-
负责人:Johnny Huard
-
依托单位:
Muscle-based tissue engineering to improve bone healing
-
批准号:7676899
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2001
-
负责人:Johnny Huard
-
依托单位:
CELL AUTONOMOUS AND NON-AUTONOMOUS MECHANISMS OF STEM CELL DEFECTS WITH AGING
-
批准号:9272342
-
项目类别:
-
资助金额:$26.44万
-
财政年份:--
-
负责人:Johnny Huard
-
依托单位:
CELL AUTONOMOUS AND NON-AUTONOMOUS MECHANISMS OF STEM CELL DEFECTS WITH AGING
-
批准号:8598144
-
项目类别:
-
资助金额:$28.41万
-
财政年份:--
-
负责人:Johnny Huard
-
依托单位: